4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-173736
Director sold 10,952 shares at an average $20.01 ($219,170)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kersten Dirk · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-21 | Sale : show line 1 in the form 10b5-1 | −8,300 | $20.01 | $166,120 | 4,199,225 | I |
| 2026-04-22 | Sale : show line 2 in the form 10b5-1 | −2,652 | $20.00 | $53,049 | 4,196,573 | I |
| Open-market sales · 10,952 sh · avg $20.01 · $219,170 | ||||||
Loading xslF345X06/ownership.xml…